Predicting cellular response to paclitaxel in epithelial ovarian cancer
Wednesday, November 16, 2011 - 11:30
in Health & Medicine
(Medical Xpress) -- New research findings by UCD scientists published online in the Journal of Pathology may help clinicians predict how patients with high grade, serous, epithelial ovarian cancer will respond to paclitaxel chemotherapy (Taxol).